VIA
ABBV icon

Victrix Investment Advisors’s AbbVie ABBV Stock Holding History

Victrix Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.78M Buy
11,038
+1,624
+17% +$349K 1.16% 29
2026
Q1 		$2.05M Sell
9,414
-581
-6% -$129K 0.74% 39
2025
Q4 		$2.28M Sell
9,995
-658
-6% -$150K 0.88% 36
2025
Q3 		$2.47M Buy
10,653
+957
+10% +$195K 1.35% 26
2025
Q2 		$1.8M Buy
9,696
+867
+10% +$161K 0.8% 39
2025
Q1 		$1.83M Buy
8,829
+3,068
+53% +$596K 0.96% 38
2024
Q4 		$1.02M Buy
+5,761
New +$1.06M 0.74% 34

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Victrix Investment Advisors's ABBV Position: Q2 2026 in Review

Victrix Investment Advisors increased its AbbVie (ABBV) stake by 17% in Q2 2026, buying an estimated $349K and bringing the position to 11,038 shares worth $2.78M. The position accounts for 1.16% of the portfolio, ranked #29.

Victrix Investment Advisors first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Victrix Investment Advisors held 11,038 shares of AbbVie worth $2.78M as of Q2 2026.
  • Victrix Investment Advisors bought 1,624 AbbVie shares in Q2 2026, an estimated $349K.
  • AbbVie made up 1.16% of Victrix Investment Advisors's portfolio in Q2 2026, its #29 holding.
  • Victrix Investment Advisors first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Victrix Investment Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.